Patent ID: 8247448

Claim:
A method of treating dyslipidaemia, atheroschlerosis or diabetes comprising administering to a patient in need thereof a therapeutically effective amount of a compound of the formula I: in which R 1 represents a (C 6 -C 18 )aryl group, which is optionally substituted and/or optionally fused to a saturated or unsaturated, monocyclic or polycyclic 5- to 8-membered nucleus optionally containing one or more hetero atoms chosen from O, N and S, said nucleus itself being optionally substituted; an optionally substituted, saturated, unsaturated or aromatic 5- to 8-membered monocyclic heterocyclic group containing one or more hetero atoms chosen from O, N and S; an optionally substituted C 2 -C 10 alkenyl group; or a C 1 -C 10 alkyl group; R 2 and R 3 independently represent a hydrogen atom an optionally substituted (C 6 -C 18 )aryl; or alternatively R 2 and R 3 together represent a C 3 -C 6 alkylene chain; and R represents a hydrogen atom; a C 1 -C 10 alkyl group or a (C 6 -C 18 )aryl(C 1 -C 10 )alkyl group; or a salt thereof with acids or bases, or a pharmaceutically acceptable derivative, or stereoisomer thereof, including mixtures thereof in all proportions with the proviso that the following compounds are excluded from the protection: the compounds where R 3 =phenyl, R=ethyl, R 1 =ethyl or phenyl and R 2 =H.